by admin | Aug 7, 2019 | News
hVIVO successfully completes RSV challenge study in Older Adults London, UK – 6 August 2019: hVIVO plc (AIM: HVO), an industry leading clinical development services business pioneering human disease models based upon viral challenge, announces the successful...
by admin | Feb 13, 2019 | Events
Investment Forum Location: Queen Mary Innovation Centre, 5 Walden Street, London, E1 2EFDate: 13th FebruaryTime: 14.00 – 19.30 The track record of success delivered by London’s academic institutions, their commercial teams and the spin out companies they have...
by admin | Sep 20, 2018 | News
Queen Mary joins London cancer research powerhouse The city of London will be transformed into a world leading hub for cancer biotherapeutics research and treatment, with a new £14 million investment from Cancer Research UK, announced today. The new Cancer Research...
by admin | Sep 5, 2016 | News
hVIVO Landmark Asthma Stratification Initiative Underway hVIVO plc (AIM: HVO), the pioneer of human disease models, is delighted to announce that the Company’s landmark asthma stratification initiative is now underway, with the first volunteer inoculated with human...
